Oncolytic Biotechnology

Oncolytic Biotechnology is the study of oncolytic virus, the virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune responses.

    Related Conference of Oncolytic Biotechnology

    July 15-16, 2020

    12th World Congress and Expo on Stem Cell Research

    Prague, Czech Republic
    July 15-16, 2020

    25th World Biotechnology Congress

    London, UK
    September 21-22, 2020

    14th International Conference on Genomics & Pharmacogenomics

    Vancouver, Canada
    September 23-24, 2020

    24th European Biotechnology Congress

    Berlin, Germany
    October 19-20, 2020

    7th Asia Pacific Geriatrics and Gerontology Congress

    Tokyo, Japan
    October 23-24, 2020

    2nd International Conference on Biomarkers and Cancer Targets

    Cape Town, South Africa
    November 16-17, 2020

    International Conference on Genomics and Molecular Biology

    Lisbon, Portugal
    November 19-20, 2020

    24th European Biotechnology Congress (EBC_2020)

    London, UK
    November 23-24, 2020

    International Conference on Toxicogenomics

    Bali, Indonesia
    December 07-08, 2020

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia

    Oncolytic Biotechnology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in